Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Robert Bradway
Age : 55
Public asset : 80,029,544 USD
Country of residence : Unknown
Linked companies : Amgen, Inc. - Boeing Co

Mr. Robert A. Bradway is an Independent Director at The Boeing Co., a Chairman & Chief Executive Officer at Amgen, Inc., a Chairman at CEO Roundtable on Cancer, Inc. and a Chairman at Pharmaceutical Research & Manufacturers of America.

He is on the Board of Directors at The Boeing Co., University of Southern California and Amgen Rockville, Inc. Mr. Bradway was previously employed as an Independent Director by Norfolk Southern Corp., a Principal by Morgan Stanley & Co., Inc., a Chief Financial Officer & Director by Alantos Pharmaceuticals Holding, Inc., and a Managing Director by Morgan Stanley & Co. International Plc.

He received his undergraduate degree from Amherst College and an MBA from Harvard University.

Current positions of Robert Bradway 
NameTitle Since
Amgen, Inc.
Chairman & Chief Executive Officer 2006
Boeing Co
(Aerospace & Defense)
Independent Director 2016
Pharmaceutical Research & Manufacturers of America Chairman -
CEO Roundtable on Cancer, Inc. Chairman -
University of Southern California Trustee 2014
Amgen Rockville, Inc. Director 2012
American Heart Association, Inc. Member -

Holdings of Robert Bradway 
Amgen (AMGN)
431,1010.065%79,576,934 USD
Norfolk Southern Corporation (NSC)
Ground Freight & Logistics
3,0000.0011%452,610 USD
Boeing Company (The) (BA)
Aerospace & Defense
00.0000%0 USD

Robert Bradway : Personal Network 

Biography of Robert Bradway 
Robert A. Bradway is the current Chairman and Chief Executive Officer of Amgen. Previously, He was the president and chief operating officer from May 2010 to May 2012. In 2011, He was appointed to the Amgen Board of Directors.
Bradway joined Amgen in 2006 as vice president, Operations Strategy, and served as Executive Vice president and Chief Financial Officer from April 2007 to May 2010.

Career at Morgan Stanley
Before joining Amgen, Bradway was the MD for banking department and corporate finance Europe, for Morgan Stanley in London. In 1985, He joined Morgan Stanley in New York as a health care industry investment banker. He then moved to London in 1990 where he served as head of Morgan Stanley's international health care investment banking activities. He subsequently, assumed responsibility for corporate finance management.

Bradway holds a B.S. degree in Biology from Amherst College and an MBA from Harvard University.

*Member of the board of directors of Norfolk Southern Corporation
*Member of the Audit and Governance committees of Norfolk Southern Corporation

Source @ Wikipedia

Most Read News 
07/17ELON MUSK : Tesla shares fall after CEO Musk abuses British caver
07/20DANIEL LOEB : Japan firms tap banks for advice as activists circle
07/18JAMES GORMAN : Morgan Stanley boss Gorman hits out at Fed stress tests
07/19MASAYOSHI SON : SoftBank's Son says Japan is 'stupid' to disallow ride-sharing
07/21SERGIO MARCHIONNE : Fiat Chrysler names Jeep boss to replace stricken CEO Marchionne
07/19JOHN BROWN : General Electric's power unit faces threat in Saudi Arabia
07/16WARREN BUFFETT : Warren Buffett donates $3.4 billion to Gates' and family charities
07/16ULRICH LEHNER : Thyssenkrupp in leadership turmoil as chairman quits
07/19JAMES PACKER : Billionaire James Packer quits 22 boards, deepens corporate withdrawal
07/15ANTTI HERLIN : Thyssen and Kone owners held merger talks on elevator ops
More news

© 2018 People and Ownership :   
Robert Bradway : Connections 

Latest news about Robert Bradway 
2017CEOs suggest Trump tax cut may lift investors more than jobs
2017CEOs suggest Trump tax cut may lift investors more than jobs
2017AMGEN : quarterly profit tops expectations despite sales decline
2017AMGEN : Cost controls help offset lower Amgen first-quarter drug sales
2017AMGEN : Profit Rises on Improved Margins, Steady Top-line Growth
2017Trump Tells Pharmaceutical CEOs He Wants Prices Down
2017Trump Tells Pharmaceutical CEOs He Wants Prices Down -- Update
More news

Popular Business Leaders 
Paul Achleitner William Ackman Frank Appel Luc Besson Jeff Bezos Lloyd Blankfein Vincent Bolloré Warren Buffett Patrice Caine Vittorio Colao Tim Cook Serge Dassault Michael Dell Oleg Deripaska Patrick Drahi John Edwards Bill Gates Carlos Ghosn David Henry Heinrich Hiesinger Carl Icahn Brian Krzanich Daniel Loeb Jack Ma Sergio Marchionne Laurent Mignon Dennis Muilenburg Rupert Murdoch Elon Musk Xavier Niel Frédéric Oudéa Gavin Patterson Georges Plassat Wolfgang Porsche Roberto Quarta Sumner Redstone Wilbur Ross Howard Schultz Masayoshi Son George Soros Martin Sorrell Rupert Stadler Peter Thiel Viktor Vekselberg François Villeroy De Galhau John Williamson Martin Winterkorn Steve Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders